Immunocytokine | Control group | Experiment Group A | Experiment Group B | t value | P value |
IFN-r | 1.27 ± 0.314 | 0.85 ± 0.20 |
| 7.209 | 0.001 |
IFN-r | 1.27 ± 0.314 |
| 0.39 ± 0.192 | 16.011 | 0.001 |
IFN-r |
| 0.85 ± 0.20 | 0.39 ± 0.192 | 11.547 | 0.001 |
IL-12 | 10.07 ± 1.259 | 8.52 ± 1.078 |
| 6.899 | 0.001 |
IL-12 | 10.07 ± 1.259 |
| 6.28 ± 1.183 | 15.604 | 0.001 |
IL-12 |
| 8.52 ± 1.078 | 6.28 ± 1.183 | 9.703 | 0.001 |
IL-15 | 4.40 ± 1.091 | 3.29 ± 1.170 |
| 4.834 | 0.001 |
IL-15 | 4.40 ± 1.091 |
| 1.97 ± 0.886 | 12.064 | 0.001 |
IL-15 |
| 3.29 ± 1.170 | 1.97 ± 0.886 | 6.244 | 0.001 |
IL-18 | 138.27 ± 9.265 | 92.08 ± 7.960 |
| 25.068 | 0.001 |
IL-18 | 138.27 ± 9.265 |
| 59.58 ± 6.742 | 47.583 | 0.001 |
IL-18 |
| 92.08 ± 7.960 | 59.58 ± 6.742 | 22.913 | 0.001 |
DC cell | 1.47 ± 0.339 | 1.51 ± 0.214 |
| 1.231 | 0.222 |
DC cell | 1.47 ± .339 |
| 1.55 ± 0.212 | 0.387 | 0.700 |
DC cell |
| 1.51 ± 0.214 | 1.55 ± .212 | −0.930 | 0.355 |
DC Cell viability | 0.98 ± 0.012 | 0.98 ± 0.013 |
| −0.472 | 0.638 |
DC Cell viability | 0.98 ± 0.012 |
| 0.98 ± 0.090 | −1.510 | 0.135 |
DC Cell viability |
| 0.98 ± 0.013 | 0.98 ± 0.090 | −0891 | 0.375 |
TNF-a | 8.09 ± 0.748 | 5.57 ± .644 |
| 16.035 | 0.001 |
TNF-a | 8.09 ± 0.748 |
| 3.33 ± 0.646 | 30.566 | 0.001 |
TNF-a |
| 5.57 ± .644 | 3.33 ± 0.646 | 79.007 | 0.001 |
NKG2D | 2.02 ± 0.252 | 1.65 ± .127 |
| 8.727 | 0.001 |
NKG2D | 2.02 ± 0.252 |
| 1.45 ± 0.136 | 13.197 | 0.001 |
NKG2D |
| 1.65 ± .127 | 1.45 ± 0.136 | 7.279 | 0.001 |